Two species of glycosylated type C viral core polyprotein were identified on the surface of AKR spontaneous leukemia cells. One of these cell surface polyproteins was shown by immunoprecipitation to have antigenic determinants of murine leukemia virus p30, p15, p12, and plO; the other had murine leukemia virus p30, p15, and p12, but not plO, determinants. Both species were also expressed on thymocytes from 6-month-old, preleukemic AKR mice.
Recently, a polyprotein species containing antigenic determinants of several murine leukemia virus (MuLV) core proteins was identified on the surface of AKR spontaneous leukemia cells (19) . Although this species was not found on thymocytes from 2-month-old AKR mice, its expression is not restricted to leukemic cells, since substantial quantities of polyprotein could be found on thymocytes from 6-month-old mice that were still preleukemic. In this report, we present more detailed studies on the nature of this polyprotein, which reveal that this species is actually a complex of two virus-specified polypeptides, both glycosylated.
Three methods by which this complex can be isotopically labeled are shown in Fig. 1 . (i) AKR spontaneous leukemia (SL) cells were labeled with 1251 by the lactoperoxidase method (19) . After Nonidet P-40 (NP-40) lysis and precipitation with anti-p30 serum, analysis of the immunoprecipitate by sodium dodecyl sulfatepolyacrylamide gradient gel electrophoresis (SDS-PAGE) revealed two components migrating close together in the region of molecular weight >70,000 (Fig. 1A, track 3 ). These were designated gP95 and gP85 ("gP" = glycosylated polyprotein), since the molecular weights of the two components were estimated by coelectrophoresis with protein markers to be 95,000 and 85,000, respectively. I A tentative molecular weight of 75,000 and the designation p(75) were originally assigned to the complex (19) . Since these proteins are derived from the MuLV gag gene locus, a more complete designation for these components would be gP85 aK and gP95 ae, as proposed at a recent meeting of workers in this field (NCI Tumor Viral Immunology Work- shop, March 1977).] Anti-NTD serum, which has antibodies against a number of MuLV proteins (8, 16, 17) , precipitated gp7O in addition to gP95 and gP85 (track 1). As expected, anti-gp7O serum precipitated only gp7O (track 2). (ii) AKR SL cells were labeled with [3H]-glucosamine in culture for 5 h (19), and a cell lysate was prepared and analyzed as before. The results showed that both gP95 and gP85 could be labeled with glucosamine (Fig. 1B,  track 2 ). Glucosamine-labeled gp7O, but not the gP95 or gP85 components, was precipitated by anti-gp7O serum as before (track 1). The precipitation of gP95 by anti-plO serum will be discussed below (see Fig. 2 ). (iii) When AKR SL cells were labeled with sodium boro[3H]-hydride by the galactose oxidase method (7), both gP95 and gP85 were again labeled (Fig.  1C, track 1) . The result demonstrated that both components contain galactose as well as glucosamine and confirms the cell surface location of these molecules.
It seemed of interest to determine whether gP95 and gP85 could be distinguished by properties other than their electrophoretic mobilities. Figure 2 shows a comparison of AKR thymocytes and AKR SL cells with respect to the serological specificities of cell surface viral core polyproteins. The thymocytes were taken at 6 months of age, a time when the tissue is, in general, morphologically normal, although it displays an enhanced level of certain MuLVspecific gene products (9, 10, 19) . Figure 2A (track 5) shows that both components are present on 6-month-old thymocytes; therefore, neither one is, strictly speaking, leukemia specific. However, in the course of testing lysates When radioiodinated SL cells were incubated at 370C, both gP95 and gP85 components disappeared from the cell surface (Fig. 3A) . The rates of disappearance, however, were different: that of gP95, especially in the first 2 h, was faster than that of gP85 (compare with Fig. 1A) . gP95 was readily detectable in the medium (Fig. 3B) , suggesting that this component, at least, was exfoliated from the cell surface. Therefore, gP95 and gP85 differ not only in their physical and serological characteristics but also in their physiological behavior.
As mentioned above, recent evidence from our laboratory indicates that cell surface MuLV core polyproteins carry determinants of the Gross cell surface antigen (GCSA) (15) . Similar data have been obtained by Ledbetter and Nowinski (12) . Both gP95 and gP85 are precipitable by the GCSA typing serum, C57BL/6 anti-AKR spontaneous leukemia K36 (anti-K36) (J.-S. Tung and E. Fleissner, unpublished data); thus, both components apparently carry GCSA determinants, although absorption studies (see reference 15) will be necessary to prove this point unequivocally. On the standard GCSA typing cell, Ed G2 and anti-K36 serum, as well as anti-MuLV p30 sera, also detect a larger cell surface species, termed p(150), which may not be glycosylated (15) . If this species is present on AKR SL cells, it is in considerably lower amounts, since we have not been able to detect it in the experiments presented in this report.
Kawashima et al. (9) have described physiological changes involving GCSA and the MuLV-specific G, antigen (a type-specific determinant of cell surface MuLV gp7O 113, 17 It is tempting to relate the physical and antigenic differences between gP95 and gP85 (allowing for effects of glycosylation) to the differAntisera were (1) anti-Rp3O and (2) normal rabbit serum. Labeled AKR SL cells were lysed with 0.5% NP-40, cell lysates were reacted with antiserum and subsequently with anti-immunoglobulin serum, and the immunoprecipitates were washed, denatured in a mixture of 0.1% SDS, 8 M urea, and 0.1 M Tris (pH 8.6) with 2% 2-mercaptoethanol (vollvol) by boiling for 2 min, and applied to 5 to 17% gradient slab gels for electrophoresis at 24 mA per slab for 3 to 4 h (11). The gel slabs were fixed in trichloroacetic acid and washed with 7% acetic acid. Gels containing 125I-labeled samples were dried and exposed to X-ray film (Kodak XR-2) directly. Gels containing 3H-labeled samples were subjected to dimethyl sulfoxide and 2,5-diphenyloxazole treatment (4) and then dried and exposed to X-ray film. Radioactive bands identified were gP95, gP85, gp7O, and H; the last appears to represent trapping of radioactivity by the heavy chain of immunoglobulin molecules. The electrophoretic mobilities of sodium boro[3H]hydride-labeled gP95 and gP85 components were consistently faster than mobilities of the same components labeled with either 125I or [3H] glucosamine. This increase in mobilities may be due to neuraminidase treatment, which is a necessary step in galactose oxidase labeling. Protein markers phosphorylase a, bovine serum albumin, and human immunoglobulin G were used to estimate molecular weights. ence in size reported for two intracellular MuLV gag products, Pr75 and Pr65, in infected tissue culture cells (1, 5, 14, 20 (3, 6) . Thus, it must be taken into consideration in postulating a direct relationship of cell surface gP95 and gP85 to intracellular Pr75 and Pr65, that this would imply a difference in the processing of the MuLV and avian viral gag products for virion assembly -in particular with respect to the functionality of the viral proteins that are the first to be split off. This and other models for the origin of gP95 and gP85 are currently being tested.
